Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Active substance : ivermectine
  • Topics : Infectious diseases
  • Topics : Biology (laboratory tests)
  • Topics : Parasitic diseases and mycoses
  • Topics : Diseases and conditions
Filter
Topic
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Diagnostic techniques and procedures (2)
    • Plus ...
      • Biology (laboratory tests) (2)
  • Diseases and conditions (2)
  • Plus ...
    • Infectious diseases (2)
    • Plus ...
      • Parasitic diseases and mycoses (2)
    • Eye diseases (1)
    • Blood and lymphatic diseases (1)
    • Plus ...
      • Lymphatic diseases (1)
    • Skin and connective tissue diseases (1)
Content type
  • Drugs, devices and medical acts (2)
  • Plus ...
    • Health technology assessment (2)
Language
  • Français (2)
Active substance
  • albendazole (2)
  • alcool (1)
  • doxycycline (1)
  • ivermectine (2)
 More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 2 results

  • Update of the Nomenclature of Laboratory Medicine Procedures for the diagnosis and monitoring of filariasis - INAHTA Brief

    Health technology assessment - Posted on 16/4/2018
    Download document
    Add to my selection

  • Update of laboratory medicine procedures related to the diagnosis of strongyloidiasis - INAHTA Brief

    Health technology assessment - Posted on 25/4/2017
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
ZyqVmASpY7r7AuvT